Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | Director · President and CEO | February 05, 2026 | February 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date February 05, 2026 · Filed February 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.62 · Expires 2035-12-15 | Direct | 145,252 |
Reported balance
After 2026-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-05 · Gift · Disposed 145,252 · Balance 145,252 F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.62 · Expires 2035-12-15 | IndirectBy a trust | 145,252 |
Reported balance
After 2026-02-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-05 · Gift · Acquired 145,252 · Balance 145,252 F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. F3: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Filing footnotes · ownership attribution and instrument terms
F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.
F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
F3: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2026 Filed Feb 9, 2026 16:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 145,252 | $0.00 Strike: $66.62 | $0.00 |
DisclosureSEC source: 0001193125-26-042838 · ownership.xml · derivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 145,252 Underlying: Class A Common Stock · 145,252 shares Expires 2035-12-15 F1 · kind: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2 · derivative.exercise_date: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. F3 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 16:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 145,252 | $0.00 Strike: $66.62 | $0.00 |
DisclosureSEC source: 0001193125-26-042838 · ownership.xml · derivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,252 Underlying: Class A Common Stock · 145,252 shares Expires 2035-12-15 F1 · kind: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2 · derivative.exercise_date: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 80 | $67.54 | $5,403.20 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 98,377 F10 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,671 | $67.24 | $448,525.35 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 98,457 F12 · price: The shares were sold in multiple transactions at prices ranging from $66.49 to $67.48, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F10 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,994 | $67.16 | $335,415.02 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 105,128 F11 · price: The shares were sold in multiple transactions at prices ranging from $67.00 to $67.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F10 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 21,772 | $66.64 | $1,450,894.79 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 110,122 F8 · price: The shares were sold in multiple transactions at prices ranging from $65.98 to $66.975, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F9 · balance_after: Includes 33,517 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the reported transactions. F10 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 6,855 | $66.62 | $456,680.10 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,784 F5 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F7 · balance_after: Shares held following the reported transaction (i) include 143,784 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 6,751 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 17,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · derivative · entry 12 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,633 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F15 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 27,273 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 17,633 PSUs. The remaining 9,640 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F15 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 27,273 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 17,633 PSUs. The remaining 9,640 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 145,252 | $0.00 Strike: $66.62 | $0.00 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · derivative · entry 11 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,252 Underlying: Class A Common Stock · 145,252 shares Expires 2035-12-15 F14 · derivative.exercise_date: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 32,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · derivative · entry 10 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,984 Underlying: Class A Common Stock · 32,984 shares Expires not disclosed F13 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F13 · derivative.exercise_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F13 · derivative.expiration_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 27,180 | $67.54 | $1,835,737.20 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,390 F5 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transaction (i) include 157,390 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 18,017 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 17,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F4 · balance_after: Shares held following the reported transactions (i) include 193,703 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 8,749 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 65,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323431 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,703 F1 · acquired: Award represents a total of 65,968 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 193,703 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 23,752 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 0 Underlying: Class A Common Stock · 23,752 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,615 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · derivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 0 Underlying: Class A Common Stock · 10,615 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,199 | $67.51 | $418,464.73 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 98,377 F3 · price: The shares were sold in multiple transactions at prices ranging from $67.39 to $67.60, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 28,168 | $66.99 | $1,887,027.84 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 104,576 F2 · price: The shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,752 | $45.50 | $1,080,716.00 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 132,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 17:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,615 | $64.60 | $685,729.00 |
DisclosureSEC source: 0001193125-25-316180 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 108,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftClass A Common Stock | 16,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 98,377 F3 · kind: On November 26, 2025, Mr. Yeaman gifted 16,348 shares of Class A Common Stock to a Donor-Advised Fund for the purpose of making charitable donations. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,699 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 23,752 Underlying: Class A Common Stock · 11,699 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · derivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 10,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 36,699 | $66.91 | $2,455,405.31 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F2 · price: The shares were sold in multiple transactions at prices ranging from $66.53 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 11,699 | $64.60 | $755,755.40 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 151,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 20:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0001193125-25-301000 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-25-241720 · ownership.xml · derivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 35,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 13,786 | $69.17 | $953,618.98 |
DisclosureSEC source: 0001193125-25-241720 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F3 · price: The shares were sold in multiple transactions at prices ranging from $68.89 to $69.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 11,214 | $68.51 | $768,222.92 |
DisclosureSEC source: 0001193125-25-241720 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 128,511 F2 · price: The shares were sold in multiple transactions at prices ranging from $67.83 to $68.81, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0001193125-25-241720 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 17:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-25-207589 · ownership.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 60,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 17:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 25,000 | $71.66 | $1,791,490.00 |
DisclosureSEC source: 0001193125-25-207589 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F2 · price: The shares were sold in multiple transactions at prices ranging from $71.285 to $71.88, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 17:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0001193125-25-207589 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 17:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0000950170-25-109039 · ownership.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 85,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 17:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 25,000 | $72.31 | $1,807,827.50 |
DisclosureSEC source: 0000950170-25-109039 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F2 · price: The shares were sold in multiple transactions at prices ranging from $71.63 to $72.59, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 17:01 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0000950170-25-109039 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,491 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · derivative · entry 11 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 35,451 Underlying: Class A Common Stock · 2,491 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,491 | $75.00 | $186,825.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,491 | $64.60 | $160,918.60 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 117,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,875 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · derivative · entry 10 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 37,942 Underlying: Class A Common Stock · 14,875 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · derivative · entry 9 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 110,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 280 | $75.30 | $21,084.90 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F3 · price: The shares were sold in multiple transactions at prices ranging from $75.30 to $75.305, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 39,595 | $74.81 | $2,962,204.90 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 115,005 F2 · price: The shares were sold in multiple transactions at prices ranging from $74.30 to $75.245, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 14,875 | $64.60 | $960,925.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 154,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0000950170-25-096726 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:06 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0000950170-25-090574 · ownership.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 135,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:06 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 25,000 | $74.02 | $1,850,530.00 |
DisclosureSEC source: 0000950170-25-090574 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F2 · price: The shares were sold in multiple transactions at prices ranging from $73.34 to $74.33, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:06 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0000950170-25-090574 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,683 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 52,817 Underlying: Class A Common Stock · 8,683 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · derivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 160,615 Underlying: Class A Common Stock · 25,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 179 | $76.57 | $13,706.03 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,725 F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.